Corbus Board News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Corbus Board. Real-time updates on events, politics, business and more.

Corbus Pharmaceuticals Reports Fourth Quarter 2022 and Year-End Financial Results and Provides Corporate Update

March 7, 2023

Company expands precision oncology pipeline with licensing of CRB-701, clinical-stage Nectin-4 antibody drug conjugate (ADC) from CSPC Pharmaceutical Group CRB-701 Phase 1 dose escalation ongoing in

United States United Kingdom Sean Moran Dennis Riedl Yuval Cohen Yong Ben

Source: finanznachrichten.de

Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of Directors

September 26, 2022

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), an immunology company, today announced the appointment of...

New York United States Robert Wood Johnson Medical School New Jersey Rutgers University New York University

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Corbus Board News Today

Corbus Pharmaceuticals Reports Fourth Quarter 2022 and Year-End Financial Results and Provides Corporate Update

Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of Directors

Explore More Categories